RT-PCR tyrosinase expression in the peripheral blood of melanoma patients

Authors: Quaglino, Pietro; Savoia, Paola; Osella-Abate, Simona; Bernengo, Maria Grazia

Source: Expert Review of Molecular Diagnostics, Volume 4, Number 5, September 2004 , pp. 727-741(15)

Publisher: Expert Reviews

Buy & download fulltext article:

OR

Price: $73.00 plus tax (Refund Policy)

Abstract:

Controversial data are reported in the literature concerning the role of peripheral blood tyrosinase messenger RNA reverse transcription PCR analysis in melanoma patient management. Some papers assess the clinical relationship between tyrosinase expression and disease outcome, while others address the high degree of variability in the positive rate percentage and demonstrate the transient shedding of melanoma cells in the bloodstream. An overview of the current knowledge about the applications and limitations of tyrosinase analysis compared with other biologic markers is presented herein. Tyrosinase expression should not be considered as a tumor burden-related marker in the peripheral blood, but rather as a measure of the potential increased risk of metastatic spreading. In this view, reverse transcription PCR gains a clinical significance when sequential determinations are performed during follow-up, whereas the evaluation of a single sample, either positive or negative, does not bring any additional clinical information.

Keywords: biologic markers; melanoma follow-up; melanoma prognosis; peripheral blood; RT-PCR; tyrosinase mRNA

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737159.4.5.727

Publication date: 2004-09-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page